GIGeetha Iyer

Geetha Iyer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Geetha Iyer has a total of 151 co-authors. Here are the top co-authors by number of shared publications:

  • Bhaskar Srinivasan

    Dr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, CJ Shah Cornea Services, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India

    35 shared publications
  • Shweta Agarwal

    C. J. Shah Cornea Services, Dr. G Sitalakshmi Memorial Clinic for Ocular Disorders, SN-Sanmar Center of Excellence for SJS, Medical Research Foundation, Sankara Nethralaya, Chennai, 600 006, India

    28 shared publications
  • Bhaskar Srinivasan

    Sankara Nethralaya

    8 shared publications
  • Shweta Agarwal

    CJ Shah Cornea Services, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India; and

    8 shared publications
  • Manokamna Agarwal

    C J Shah Cornea Services, Dr. G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, Sankara Nethralaya, Chennai, Tamil Nadu, India

    5 shared publications
  • Pukhraj Rishi

    Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India

    5 shared publications

Latest Publications

  • Visual and Therapeutic Outcomes of Scleral Lens in Pediatric Ocular Surface Diseases

    by Mugundhan Rajarajan, Suhita Mathimaaran, Madhumathi Subramanian, Ronit Dutta, Varsha Bhambhani, Geetha Iyer, Bhaskar Srinivasan, Shweta Agarwal

    Purpose: To evaluate the long-term visual and therapeutic outcomes of scleral lenses in pediatric patients with ocular surface disorders over a 17-year period at a tertiary eye care center. Methods: This retrospective observational study included pediatric patients (≤18 years) with ocular surface disorders who underwent scleral lens fitting between 2008 and 2025 at a tertiary center in South India, with a minimum follow-up of 12 months. Data extracted from electronic medical records included demographics, diagnosis, best-corrected visual acuity (BCVA), corneal neovascularization, surface keratinization, lubricant dependence, prior surgeries, and lens-related complications. Corneal neovascularization and keratinization were graded on a 0 to 3 scale. Snellen BCVA was converted to logMAR for analysis. Primary outcomes were change in visual acuity and ocular surface parameters. Results: Ninety-one eyes of 67 pediatric patients (45 males, 22 females) were analyzed. Mean age at lens insertion was 10.63 ± 3.23 years (range 4–17), with mean follow-up of 40.0 ± 22.32 months. Among eyes with chemical injury, 10/14 had prior simple limbal epithelial transplantation, whereas 22/75 eyes with Stevens–Johnson syndrome underwent symblepharon release before fitting. BCVA improved significantly ( P < 0.05) after lens fitting. Corneal neovascularization decreased in 73% of eyes, lubricant dependence reduced in 41.8%, and 66.7% of SJS eyes showed reduced keratinization. Complications included conjunctival impingement (12%) and lens breakage (2.2%); no lens-related infections occurred. Conclusions: Scleral lenses provide safe, sustained visual improvement and ocular surface stabilization in pediatric ocular surface disease and should be considered an integral component of multidisciplinary care.

  • Symblepharon Release and Fornix Reconstruction after Ocular Chemical Injury: Outcomes from a Decade-Long Clinical Experience

    by Varsha Bhambhani, Mridula Vijayaraghavan, Mugundhan Rajarajan, Bhaskar Srinivasan, Geetha Iyer, Janani Surya, Ahmad Kheirkhah, Shweta Agarwal

    Purpose: To evaluate anatomical, visual and cosmetic rehabilitation outcomes of symblepharon release with fornix reconstruction (SR-FR) in eyes with chronic chemical injury and identify factors influencing surgical success. Methods: Retrospective observational study of patients undergoing SR-FR for chemical injury-related symblepharon over 10 years at a tertiary eye care centre. Symblepharon severity, surgical techniques, epithelial healing and demographics were recorded. Anatomical (success, partial success and failure), visual rehabilitation and cosmetic rehabilitation outcomes were analysed. Multivariate ordinal logistic regression identified factors associated with anatomical outcome. Results: The study involved 125 fornices in 118 patients. Median age at injury was 7 years (IQR 4–19) and at SR-FR 12 years (IQR 5–24), with a median follow-up of 15 months (IQR 8–36). Successful anatomical outcome was achieved in 61.6% after the first procedure, increasing to 84.8% after final reconstruction. Severe symblepharon was associated with lower success rates and greater need for repeat attempts (p=0.027). On multivariate analysis, symblepharon grade was an independent predictor of anatomical outcome (p=0.005), while epithelial healing was associated with improved outcome (p=0.046); delayed epithelial healing was independently associated with poorer outcome (p=0.011); age, gender, chemical type, mitomycin-C use and fornix-forming sutures were not significant. Visual improvement was independent of anatomical success and primarily limited by ocular comorbidities. Conclusions: SR-FR is an effective approach for anatomical restoration. Symblepharon severity is an independent predictor of outcome, while delayed epithelialisation is a clinically relevant early postoperative indicator of poorer outcomes. Visual recovery is largely determined by associated ocular comorbidities.

  • Insights from 1096 clinical cases: pioneering a universal grading system for vernal keratoconjunctivitis management

    by Ambika Chandrasekar, Shweta Agarwal, Gaurav Chauhan, Bhaskar Srinivasan, Varsha Bhambani Chavda, Geetha Iyer

    Aim: To analyse the clinical and demographic profiles of patients with vernal keratoconjunctivitis (VKC) and propose a grading for VKC based on corneal status and symptom periodicity rather than disease activity. Methods: Retrospective observational study from January 2015 to January 2020 in India. VKC grading was based on past/present clinical signs and frequency of symptoms rather than disease activity. The electronic medical records were screened and details of VKC patients diagnosed by cornea specialists were recorded and analysed. Results: 1096 VKC patients with a mean age of onset of 7.05±5.3 with 8.39% having adult onset were analysed. Symptoms included; itching (50.55%) and decreased vision (15.44%). Mixed VKC (52.04%) was the most common presentation with 49.1% having active disease. Complications included; keratoconus (18.43%), steroid-induced cataract (11.41%), glaucoma (10.95%) and limbal stem cell deficiency (5.29%). Dual-acting antiallergics (69.39%) were most commonly used, followed by topical immunomodulators. The patients were graded as, grade I: mild—presence of mild and seasonal symptoms and/or signs. Grade II: moderate—presence of persistent symptoms/and/or signs without corneal involvement. Grade III: severe—chronic persistent symptoms/and/or intermittent signs with corneal involvement or asymptomatic to mild symptoms with corneal pathognomonic signs. Grade IV: very severe—chronic persistent symptoms and/or corneal pathognomonic signs or active involvement/complication or asymptomatic with complications. Conclusion: VKC is a chronic disease that often causes visual complications. The new grading system based on the cornea status and symptom periodicity rather than disease activity might help plan the management better.


  • Unique cytokine signature in ocular Stevens-Johnson syndrome non-responders

    by Srividya Gurumurthy, Bhaskar Srinivasan, Shweta Agarwal, Hiren Matai, Narayanasamy Angayarkanni, Geetha Iyer


  • Corneal Rehabilitation and Anterior Segment Reconstruction

    by Bhaskar Srinivasan, Geetha Iyer, Shweta Agarwal, Chetan Rao, Sripriya Krishnamurthy

  • Open Access

    Aqueous deficiency dry eye in post conjunctivitis cicatrization - Effect of deep thermal punctal cautery

    by Manokamna Agarwal, Bhaskar Srinivasan, Shweta Agarwal, Sunita Pandey, Shobha P S Kumar, Soumen Sadhu, S Saranya, Geetha Iyer

    Purpose: To evaluate the effect of deep thermal punctal cautery in eyes with post-conjunctivitis cicatrization. Methods: This retrospective study consisted of patients who underwent deep thermal punctal cautery for post-conjunctivitis dry eye (PCDE). The diagnosis was based on a history suggestive of viral conjunctivitis in past followed by the onset of present clinical features of aqueous deficiency dry eye (ATD). All patients underwent a rheumatological evaluation to rule out underlying systemic collagen vascular disease as a cause for dry eye. The extent of cicatricial changes was noted. Best-corrected visual acuity (BCVA), Schirmer’s test, and fluorescein staining score (FSS; total score of 9) were analyzed pre- and post-cautery. Results: Out of 65 patients (117 eyes), 42 were males. The mean age at presentation was 25.769 ± 12.03 years. Thirteen patients presented with unilateral dry eye. Pre-cautery BCVA (logarithm of the minimum angle of resolution [logMAR]) and Schirmer’s test (mm) improved from 0.5251 ± 0.662 to 0.372 ± 0.595 (P value = 0.000, 95% confidence interval [CI]: 0.09–0.22), and 1.952 ± 2.763 to 4.929 ± 4.338 (P value = 0.000, 95% CI: -3.79–-2.17); post-cautery, respectively. The pre-cautery FSS of 5.9 ± 2.82 reduced to 1.58 ± 2.38 (P value = 0.000, 95% CI: 3.46–5.17) post-cautery. The mean follow-up was 11.22 ± 13.32 months. No progression in cicatricial changes was noted in any eye during the follow-up. Re-canalization rate was 10.64%, and repeat cautery was performed with successful closure of puncta. Conclusion: Symptoms and clinical signs of ATD in PCDE patients improve with punctal cautery.


  • Open Access

    E-PIX: An enhanced grading for acute ocular burns

    by Geetha Iyer, Bhaskar Srinivasan, Shweta Agarwal, Rajesh Fogla

    An enhanced online and manual grading system, based on the I’s and E’s, for acute ocular chemical injuries is being proposed. E-PIX is designed to be an online/manual grading system that includes all the parameters that adversely affect the outcome of acute chemical injuries. The importance of addressing the I’s and E’s in chemical burns cannot be underestimated. These include the need for the documentation and management of epithelial defect (E), intraocular pressure (P) (IOP), ischemia (scleral) (I), and exposure (X) (acronym - E-PIX). Epithelial defect includes that involving the limbus (L), along with conjunctival (C), corneal (K), and tarsal (T). These additional parameters are graded and represented as an annotation along with the limbal grade providing a comprehensive grading for the injury. A manual entry sheet and a freely accessible online grade generator are a part of the system. The proposed enhanced grading offers a final annotation that provides a clear understanding of all factors that can lead to vision-threatening complications ensuring their assessment and hence subsequently their addressal to improve outcomes, if abnormal. The prognostication continues to be based on the grade of limbal involvement. The additional annotations impact prognosis and outcome if not addressed. Including the laterality of injury provides, in addition, a futuristic understanding of available options. The grade generator retains the flexibility to be dynamic with changes reflecting upon the healing process in the acute stage. The proposed system aims to provide primary and tertiary caregivers alike with a uniform grading system.


  • Open Access

    Dry eye module – An application intelligence platform for diagnosing and monitoring dry eye disease

    by Geetha Iyer, Bhaskar Srinivasan, Shweta Agarwal, Sumana Chatterjee, Rishi Swarup, Priya Srinivas

    Dry Eye Module (DEM), a software application, was developed to facilitate the streamlining of dry eye evaluation and documentation, to unify diagnostic jargon, and to analyze data input to generate a dry eye diagnostic report. This diagnostic report generated is based on the current understanding of dry eye diagnostic algorithms (Dry Eye Workshop 2 [DEWS2]/Asia Dry Eye Society [ADES]). Apart from its plausible role in aiding unprecedented multicentric dry eye demographic data collection, the application software can generate a customized referral letter to the rheumatologist, highlighting the salient ophthalmic features to be shared. DEM uses schematic illustrations to depict eyelid, conjunctival, and corneal parameters that impact the ocular surface in dry eyes that can be captured and compared during serial visits. Furthermore, DEM displays a symptom sign trend chart that graphically represents improvement/stability or worsening of the subjective and objective dry eye status. DEM can generate a curated prescription using preloaded advice templates. DEM includes facility for state-of-the-art advanced dry eye diagnostic reporting for super specialty use. The addition of DEM to the dry eye diagnostic armamentarium would help bridge the current unmet needs of dry eye evaluation. These are lack of uniform reporting, lack of multicentric data on a unified platform, the inability to ensure complete evaluation, inability to avoid lacunae during follow-up visits, and the lack of a simple patient-ophthalmologist and an ophthalmologist–rheumatologist interface.


  • Open Access

    Tear cytokines and their relevance as biomarkers in ocular surface inflammatory diseases

    by Srividya Gurumurthy, Varsha Bhambhani, Shweta Agarwal, Bhaskar Srinivasan, Geetha Iyer

    Ocular surface disorders (OSDs) are complex, multifactorial diseases, often coexisting and with overlapping symptoms leading to discomfort and visual compromise. OSD is driven by chronic inflammation and its pathogenesis involves multiple ocular surface structures such as the cornea, conjunctiva, lacrimal glands, and meibomian glands. Diagnosing and monitoring disease progression based on clinical features is crucial for effective treatment implementation. However, achieving a differential diagnosis solely through clinical features can be challenging. The evaluation of biomarkers can facilitate disease diagnosis, aid in classification, and offer insights into disease progression and treatment effectiveness. There remains an unmet clinical need for biological tools to manage ocular surface diseases (OSDs). Tear fluid serves as a readily accessible source of biological material that has undergone extensive analysis in the quest for biomarkers related to OSD. Numerous studies have contributed to the extensive catalog of biomarkers found in tear fluid for OSD. The objective of this review is to provide a comprehensive and up-to-date overview of the most pertinent biomarkers for various OSDs, with a specific focus on quantitative analyses and their correlations with clinical parameters. To achieve this objective, we conducted a review of the PubMed database from January 2013 to June 2023, including original articles that investigated tear cytokines in various OSD pathologies. These studies unveiled a dysregulated interplay of pro- and anti-inflammatory cytokines within these disease pathologies. Pro-inflammatory interleukins (IL-1β, IL-2, IL-8, and IL-17), tumor necrotic factor (TNF-α), interferon-gamma (IFN-γ), as well as IL-4, IL-5, and IL-13 (Th2 pathway), and chemokines such as CCL5, IP-10 (CXCL10), and CX3CL, appear to represent similar inflammatory mechanisms in OSD pathologies. The cytokines identified through tear fluid analysis can aid in categorizing the disease as either pro-inflammatory or pro-fibrotic based on its severity, or they may serve as potential targets for intervention. This, in turn, can facilitate the planning of appropriate management strategies. The integration of biomarker testing into clinical settings holds the potential to advance personalized medicine and represents the next significant step in managing OSD.


  • Open Access

    Artificial tear substitutes: The current Indian scenario

    by Madhuvanthi Mohan, Maria T Priyanka, Bhaskar Srinivasan, Shweta Agarwal, Sanjeev P Srinivas, Srinivas K Rao, Quresh Maskati, Rajesh Fogla, Geetha Iyer

    Dry eye disease is one of the most common conditions that presents to and is managed by an ophthalmologist. Artificial tear substitutes (ATS) form the first line of and mainstay treatment of the condition. Understanding the components of ATS helps in choosing the appropriate ATS for a particular condition. The severity of the condition, with or without epitheliopathy further influences the decision making. It is essential therefore to be aware of the ingredients that constitute ATS, namely, the viscosity enhancing active agent, the biologically active excipient and most importantly, the preservative. With several lubricants available in the Indian market, this current update provides a formulary of almost all currently available ATS. It briefly highlights the role of each ingredient, selection of the appropriate ATS based on the disease, and a compilation of most lubricants available in the Indian market today.